152 related articles for article (PubMed ID: 21283548)
1. Comparative analysis of acid sphingomyelinase distribution in the CNS of rats and mice following intracerebroventricular delivery.
Treleaven CM; Tamsett T; Fidler JA; Taksir TV; Cheng SH; Shihabuddin LS; Dodge JC
PLoS One; 2011 Jan; 6(1):e16313. PubMed ID: 21283548
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
[TBL] [Abstract][Full Text] [Related]
5. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
[TBL] [Abstract][Full Text] [Related]
6. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
Bu J; Ashe KM; Bringas J; Marshall J; Dodge JC; Cabrera-Salazar MA; Forsayeth J; Schuchman EH; Bankiewicz KS; Cheng SH; Shihabuddin LS; Passini MA
Mol Ther; 2012 Oct; 20(10):1893-901. PubMed ID: 22828503
[TBL] [Abstract][Full Text] [Related]
7. Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion.
Ziegler RJ; Salegio EA; Dodge JC; Bringas J; Treleaven CM; Bercury SD; Tamsett TJ; Shihabuddin L; Hadaczek P; Fiandaca M; Bankiewicz K; Scheule RK
Exp Neurol; 2011 Oct; 231(2):261-71. PubMed ID: 21777586
[TBL] [Abstract][Full Text] [Related]
8. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.
Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR
Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014
[TBL] [Abstract][Full Text] [Related]
9. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.
Salegio EA; Samaranch L; Jenkins RW; Clarke CJ; Lamarre C; Beyer J; Kells AP; Bringas J; Sebastian WS; Richardson RM; Rosenbluth KH; Hannun YA; Bankiewicz KS; Forsayeth J
Hum Gene Ther; 2012 Aug; 23(8):891-902. PubMed ID: 22574943
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
[TBL] [Abstract][Full Text] [Related]
12. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
[TBL] [Abstract][Full Text] [Related]
13. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
[TBL] [Abstract][Full Text] [Related]
14. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
[TBL] [Abstract][Full Text] [Related]
15. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology.
Miranda SR; He X; Simonaro CM; Gatt S; Dagan A; Desnick RJ; Schuchman EH
FASEB J; 2000 Oct; 14(13):1988-95. PubMed ID: 11023983
[TBL] [Abstract][Full Text] [Related]
16. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice.
Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS
Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A.
Samaranch L; Pérez-Cañamás A; Soto-Huelin B; Sudhakar V; Jurado-Arjona J; Hadaczek P; Ávila J; Bringas JR; Casas J; Chen H; He X; Schuchman EH; Cheng SH; Forsayeth J; Bankiewicz KS; Ledesma MD
Sci Transl Med; 2019 Aug; 11(506):. PubMed ID: 31434754
[TBL] [Abstract][Full Text] [Related]
18. Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages: implications for Niemann-Pick disease enzyme replacement therapy.
Dhami R; Schuchman EH
J Biol Chem; 2004 Jan; 279(2):1526-32. PubMed ID: 14557264
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease.
Ziegler RJ; Brown C; Barbon CM; D'Angona AM; Schuchman EH; Andrews L; Thurberg BL; McPherson JM; Karey KP; Cheng SH
Mol Genet Metab; 2009 May; 97(1):35-42. PubMed ID: 19231265
[TBL] [Abstract][Full Text] [Related]
20. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
